Integra® Wound Matrix
Integra® Wound Matrix is an advanced wound care device consisting of a porous, three-dimensional dermal layer, comprised of collagen and glycosaminoglycan. The dermal layer is designed with a controlled porosity and defined degradation rate that provides a scaffold for cellular invasion and capillary growth.
• Provides immediate wound coverage
• Highly conformable for various anatomic sites
• Provides a scaffold for cellular invasion and capillary growth
• Room temperature storage
Integra® Wound Matrix is indicated for the management of wounds including: partial- and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, and skin tears) and draining wounds. The device is intended for one-time use.
This device should not be used in patients with known sensitivity to bovine collagen or chondroitin materials. This device is not indicated for use in third-degree burns.
Do not resterilize. Discard all opened and unused portions of the device. Do not use if package seal is broken.
Complications are possible with the use of wound dressings including infection, chronic inflammation, allergic reaction, excessive redness, pain or swelling.
Room temperature with a 24-month shelf life.
|Assigned HCPCS code||●|
|Shelf life greater than 2 years|
|Shelf life limited||●|
|Indicated for acute wounds||●|
|Indicated for chronic wounds||●|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for second-degree burns|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns|
|Indicated for venous ulcers||●|
|Contact manufacturer for usage guidelines|
|Educational Material Available||●|
|Free Samples/Trials Available|
|Published Clinical Article Available|
Using aseptic technique, peel open the outer pouch and gently drop the inner foil pouch onto a sterile field or surface. Using sterile technique, place foil pouch flat and peel open the inner pouch. Remove product, including the protective polyethylene sheets. Separate product from the polyethylene sheets by slowly and carefully peeling back from one of the corner edges. Handle with care as product is fragile. Place product into basin containing a sterile saline solution. Rinse the product free of storage buffer by immersion in sterile saline for 1-2 minutes. Keep product in the basin until application.
Prepare wound bed using standard methods to ensure wound is free of debris and necrotic tissue. If necessary, surgically debride the wound to ensure the wound edges contain viable tissue. Cut the device to size and apply immediately following wound bed preparation. Smooth Integra® Wound Matrix into place to ensure sheet is in contact with the underlying wound bed.
After application, use appropriate secondary dressings to maintain device adherence and protect the wound area. The optimum secondary dressing is determined by wound location, size, depth and user preference.
Change the secondary dressings as needed. Frequency of secondary dressing change will be dependent upon volume of exudate produced, type of dressing used and the clinician's need to inspect the wound bed for signs of infection or healing.
Integra LifeSciences, a worldwide leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development of cost-effective solutions used to treat millions of patients every year. With over two decades of clinical efficacy and a reputation for delivering quality, Integra's advanced wound care products are a premiere solution for clinicians.